Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.
D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005470:Fluorometry; D006426:Hemicholinium 3 / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism*; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010095:Oxotremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D010277:Parasympathomimetics; D010648:Phenylacetates; D006426:Hemicholinium 3; D001115:Arecoline; D010095:Oxotremorine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D004298:Dopamine; D006719:Homovanillic Acid